BROWN RUDNICK, LLP, ON BEHALF OF AMNEAL PHRAMACEUTICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2019

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2019	—	1	1
2018	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HOOPER, LUNDY & BOOKMAN, P.C.	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
No government targets were reported in these filings.

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2212115th Congress

CREATES Act of 2017

2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.

Cited source text and reported amounts

H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

Client expense: — · Firm income: —

Matched citations: H.R. 2212

S. 974115th Congress

Creating and Restoring Equal Access to Equivalent Samples Act of 2018

2018 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.

Cited source text and reported amounts

H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

Client expense: — · Firm income: —

Matched citations: S. 974

BROWN RUDNICK, LLP, ON BEHALF OF AMNEAL PHRAMACEUTICALS — Lobbying Disclosure | Poliscope